Application Nr Approved Date Route Status External Links
ANDA208759 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Daunorubicin Hydrochloride Injection In Combination With Other Approved Anticancer Drugs Is Indicated For Remission Induction In Acute Nonlymphocytic Leukemia (Myelogenous, Monocytic, Erythroid) Of Adults And For Remission Induction In Acute Lymphocytic Leukemia Of Children And Adults.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Daunorubicin Hydrochloride DAUNORUBICIN HYDROCHLORIDE ZINC3917708

Comments